Hematology and Oncology

The cellular therapy programs at Vanderbilt-Ingram Cancer Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt, and the VA Tennessee Valley Healthcare System have received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT).

Kimberly Dahlman, PhD, associate professor of Medicine in the Division of Hematology and Oncology, will begin serving her three-year term upon the closing of the association’s annual conference on June 17.

Research published in JAMA Dermatology by VUMC investigators, including senior corresponding author Douglas Johnson, MD, MSCI (Hematology and Oncology), provides insight into chronic cirAEs.

Faculty members Drs. Elizabeth Phillips (Infectious diseases) and Michael Savona (Hematology and Oncology) are among the six Vanderbilt University faculty members that have been elected fellows of the American Association for the Advancement of Science.

Adetola Kassim, MBBS (Hematology and Oncology), is co-first author of the paper that reported of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.

Dr. Justin Balko received funds for a project to improve antibody-drug conjugates for the treatment of HER2-positive breast cancer.

Numerous additions and appointments during the past year are enhancing Vanderbilt University Medical Center’s missions.

Nine faculty in four different divisions are among the 25 new faculty selected for membership in Vanderbilt University School of Medicine's Academy for Excellence in Education.